Nuclear medicine in Russia

Main article: Nuclear medicine

2023

Rosatom creates a center for cyclotron technologies for the development of high-tech medicine

Rosatom is creating a center for cyclotron technologies for the development of high-tech medicine. The press service of the state corporation spoke about this project at the end of September 2023. Read more here.

Rosatom built a nuclear medicine center in Moscow for billions of rubles

Rosatom has completed the construction of the nuclear medicine building at the Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology. This was announced by the general director of the state corporation Alexei Likhachev on August 14, 2023 during a working meeting with President RFVladimir Putin. Read more here.

MedInvestGroup opened a nuclear medicine center at Sechenov University for 350 million rubles

MedInvestGroup opened the Center for Nuclear Medicine at Sechenov University. The volume of investments in the project amounted to 350 million rubles. This was announced on June 9, 2023. Read more here.

In Russia, significantly increased the production of radioisotope, which is used for the therapy of inoperable forms of cancer

The State Scientific Center of the Russian Federation - the A.I. Leipunsky Institute of Physics and Energy (part of the scientific division of Rosatom State Corporation) significantly increased the production of actinium-225 (Ac-225) due to the optimization of the production process. Representatives of SSC RF - FEI JSC spoke about this at an international conference on nuclear medicine in Cape Town of the Republic of South Africa, according to a statement on the institute's website dated March 15, 2023. Read more here.

Nuclear medicine center with unique equipment opened at Sechenov University Hospital

A nuclear medicine center with unique equipment has been opened at the Sechenov University Hospital. The press service of the university announced this on February 7, 2023. Read more here.

2022

Nuclear medicine center opened in Ulan-Ude for 1.3 billion rubles

On October 21, 2022, the opening ceremony of the Center for Nuclear Medicine took place in Ulan-Ude. His patients will receive early diagnosis of cancer. Read more here.

Presented is a method of producing the most important isotope for nuclear medicine

On June 23, 2022, it became known that the Russian scientists they had developed a production method, medical lutetium-177 isotope thanks to which drugs based on it would become more affordable. The work was carried out by the researchers Institute of Geochemistry and Analytical Chemistry (GEOHI) named after V.I. Vernadsky RAS together with. Research Institute of Nuclear Physics (NIIAF) of Lomonosov Moscow State University More details. here

Rosatom will build a nuclear medicine center in the Stavropol Territory

On June 15, 2022 St. Petersburg , an agreement of intent was signed between Government of the Stavropol Territory and. "Rusatom Healthcare" The signed document fixed the intentions of the parties regarding the creation Stavropol Territory of a center for nuclear medicine the provision of specialized medical medical care in the region oncology in the conditions of round-the-clock and day hospitals. This was Zdrav.Expert reported by representatives of Rusatom Healthcare. More. here

Rosatom replaced imported products for radionuclide diagnostics and therapy

The Isotope Regional Association (part of the Rusatom Healthcare division, which accumulates the expertise of Rosatom State Corporation in the field of health) promptly provided Russian medical institutions with domestic products for radionuclide diagnostics and therapy. This was reported on April 5, 2022 by Zdrav.Expert at Rusatom Healthcare. Read more here.

2021

A nuclear medicine center was built in Buryatia for 1.38 billion rubles

In December 2021, the Sinatom company (part of the Sinar group of Dmitry Pumpyansky) announced the completion of the construction of the Center for Nuclear Medicine in Ulan-Ude. Every year in this institution it is planned to carry out more than 5.5 thousand procedures for the diagnosis of oncological, neurological and cardiovascular diseases using computed tomography, a proton cyclotron and a positron emission tomograph, and the production of radiopharmaceuticals will be established. Read more here.

Rusatom Healthcare and the Slovenian company Cosylab created a joint venture to develop software for radiation therapy

Rusatom Healthcare JSC (a division that accumulates the expertise of Rosatom State Corporation in the field of healthcare) and the Slovenian company Cosylab, specializing in the development and implementation of digital solutions in the field of nuclear medicine, created a joint venture - RuSat Digital Healthcare LLC - and began to develop software for radiation therapy. This was announced on December 9, 2021 by representatives of Rusatom Healthcare. Read more here.

Mishustin approved the creation of the Park of Atomic and Medical Technologies for 20 billion rubles

Prime Minister Mikhail Mishustin signed a decree of the Government of the Russian Federation on the creation of an innovative scientific and technological center (INTC) "Park of Atomic and Medical Technologies" in the Kaluga Region. The press service of the Cabinet of Ministers announced this on October 21, 2021. Read more here.

The government allocated 6.5 billion rubles to create innovative centers for nuclear medicine

On July 23, 2021, it became known that the Government of the Russian Federation allocates 6.5 billion rubles for the creation of innovative centers for nuclear medicine. By 2025, these funds will be used to build a typical clinical center for ion therapy at the Institute of High Energy Physics in the city of Protvino in the Moscow Region, as well as a proton beam therapy complex based on the Kurchatov Institute. Read more here.

The volume of the Russian nuclear medicine market by the end of the year will exceed 20 billion rubles

On April 11, 2021, information appeared that, according to the forecasts of "Rusatom Healthcare," the growth of the Russian nuclear medical market in the next 2-3 years will accelerate twice. The portfolio company Rosatom believes that by the end of 2021 its volume will amount to more than 20 billion rubles. For April 2021, on average, it increases by 7% per year, and will grow by 15% per year due to the expansion of technology use and an increase in the cost of services.

The volume of the Russian nuclear medicine market by the end of the year will exceed 20 billion rubles

According to forecasts of analysts at the National Research Nuclear University MEPhI, the global volume of the nuclear medicine market for April 2021 is $24 billion, and by 2030 should grow to $43 billion. Two segments are traditionally distinguished in it: for example, the market for radionuclide diagnostics on average increases by 7% per year, and for radionuclide therapy - by 28%.

The leader in nuclear to medicine for April 2021 remains. USA Also among the significant suppliers are Japan Germany Switzerland,,,,.,.,. Italy Belgium Spain France Turkey occupies Russia about 5% of the global nuclear medicine market and so far plays a significant role only in the supply of some types of isotope raw materials. To enter the country to higher positions, breakthrough scientific research, more relevant equipment, training of scientific personnel are needed, noted in. The Ministry of Industry and Trade department also stressed that the domestic nuclear medicine is rapidly developing, most manufacturers of equipment for it are included in the management circuit of Rosatom, which by 2030 plans to occupy a tenth of the world market for nuclear medicine. for nuclear Russian equipment medicine, they buy,,, are negotiating the Uzbekistan Thailand Belarus Kazakhstan export of equipment in. Turkey

The Karpov Research Institute of Physics and Chemistry is bringing to the market import-substituting a radiotherapy complex based on a linear electron accelerator with an energy of 6 MeV for high-precision radiation therapy of malignant tumors, the Ministry of Industry and Trade said. The Research Institute of Technical Physics and Automation implements a project to localize the production of linear accelerators of the company, Elekta modernizes the apparatus for second-generation brachytherapy and launches the production of its own linear accelerators of electrons for nuclear beam therapy. In cancer 2022, the institute plans to bring to the market a completely domestic linear accelerator for radiation therapy "Onyx," as well as an apparatus for second-generation brachytherapy "Brachium." Within a few years, it is planned to achieve technological independence in this direction, the Ministry of Industry and Trade emphasized.

State-owned companies, with the support of the department, also implement import substitution projects for the main components of computer tomographs and create technologies and production lines for the manufacture of an element base for X-ray diagnostic equipment.

Meanwhile, the Blokhin Institute notes that oncological diseases have become better detected in Russia, the average life expectancy of cancer patients is increasing, more people have long-term remission or complete cure. As of April 2021, a little less than 4 million people are registered in the country for cancer. The^[1].

2020: Rosatom will build an interregional center for radionuclide therapy in Lipetsk for 1.26 billion rubles

On September 11, 2020, it became known that an interregional center for radionuclide therapy will be built in Lipetsk. Between the government of the Lipetsk region and JSC "Rusatom Healthcare" an agreement was signed on the creation of the Lipetsk Regional Oncological Dispensary.

The project involves the creation in the region of a high-tech center specializing in the use of nuclear medicine technologies for the diagnosis and treatment of diseases of organs and systems of the human body. Read more here.

2019

Nuclear medicine market volume - 94 billion rubles

The volume of the Russian nuclear medicine market is more than 94 billion rubles and will actively develop on the horizon until 2030: according to forecasts of Atomenergoprom JSC (September 2020), growth will be up to 6-7% per year. Therefore, the development and commercialization of domestic FPMs is attractive both for the state health care system and for private business^[2].

Rusatom Healthcare and GE Healthcare agreed to localize technologies for nuclear medicine in the Russian Federation

On February 14, 2019, Rusatom Healthcare (RCK), an integrator in the field of radiation technologies in medicine and industry, and GE Healthcare signed a roadmap on the creation of local production of high-tech medical equipment in order to meet the growing need of the population of the regions of the Russian Federation for high-quality medical diagnosis and treatment of oncological diseases. The document was signed by the general director of Rusatom Healthcare JSC Alexander Shibanov and the president and chief executive officer of GE Healthcare in Russia/SNGNIN Kandelaki. Read more here.

Notes